Features of gender, age, social factors and polymorbidity in patients, undergone COVID-19
https://doi.org/10.18699/SSMJ20240420
Abstract
Aim of the study was to identify the features of susceptibility to a new coronavirus infection СOVID-19 depending on gender, age, social factors and polymorbidity. Material and methods. An analysis of the structural features of gender, age, and social factors in 620 patients who underwent examination and treatment at the Federal Research Center of Fundamental and Translational Medicine clinic (Novosibirsk) was carried out. The patients were divided into 2 groups: the main group (group 2, age 56.4 ± 0.7 years) included 272 patients who underwent a new coronavirus infection COVID-19, confirmed by a positive PCR test or antibody testing, a comparison group (group 1, age 60.7 ± 0.7 years) – 348 people who did not have COVID-19 and were undergoing examination and treatment for chronic non-communicable diseases. Results. An analysis of the incidence of COVID-19 depending on gender showed that disease was more common, by 22 %, in women than in men. Patients who had COVID-19 were statistically significantly more likely (30%) to be in the second adult age period than those in the comparison group. When studying the social features of patients who underwent COVID-19, it was found that employees and employees of the administrative and managerial apparatus were significantly more likely to suffer from this infectious disease. An analysis of the structure of polymorbid pathology revealed that patients with COVID-19 had a significantly higher value of transsystemic polymorbidity.
About the Authors
Yu. A. Nikolaev
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Yuriy A. Nikolaev, doctor of medical sciences
630117, Novosibirsk, Timakova st., 2
E. V. Sevostyanova
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Evgeniya V. Sevostyanova, candidate of medical sciences
630117, Novosibirsk, Timakova st., 2
I. M. Mitrofanov
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Igor M. Mitrofanov, doctor of medical sciences
630117, Novosibirsk, Timakova st., 2
V. Ya. Polyakov
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Vladimir Ya. Polyakov, doctor of medical sciences
630117, Novosibirsk, Timakova st., 2
References
1. Li L.Q., Huang T., Wang Y.Q., Wang Z.P., Liang Y., Huang T.B., Zhang H.Y., Sun W., Wang Y. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J. Med. Virol. 2020;92(6):577–583. doi: 10.1002/jmv.25757
2. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., … China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032
3. de Lusignan S., Dorward J., Correa A., Jones N., Akinyemi O., Amirthalingam G., Andrews N., Byford R., Dabrera G., Elliot A., … Hobbs F.D.R. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect. Dis. 2020;20(9):1034–1042. doi: 10.1016/S1473-3099(20)30371-6
4. Pijls B.G., Jolani S., Atherley A., Derckx R.T., Dijkstra J.I.R., Franssen G.H.L., Hendriks S., Richters A., Venemans-Jellema A., Zalpuri S., Zeegers M.P. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 2021;11(1):e044640. doi: 10.1136/bmjopen-2020-044640
5. Meister T., Pisarev H., Kolde R., Kalda R., Suija K., Milani L., Karo-Astover L., Piirsoo M., Uusküla A. Clinical characteristics and risk factors for COVID-19 infection and disease severity: A nationwide observational study in Estonia. PLoS One. 2022;17(6):e0270192. doi: 10.1371/journal.pone.0270192
6. Hobbs C.V., Drobeniuc J., Kittle T., Williams J., Byers P., Satheshkumar P.S., Inagaki K., Stephenson M., Kim S.S., Patel M.M., Flannery B.; CDC COVID-19 Response Team. Estimated Sars-Cov-2 seroprevalence among persons aged <18 years – Mississippi, may– september 2020. MMWR Morb. Mortal. Wkly. Rep. 2021;70(9):312–315. doi: 10.15585/mmwr.mm7009a4
7. Smith B.K., Janowski A.B., Danis J.E., Harvey I.B., Zhao H., Dai Y.N., Farnsworth C.W., Gronowski A.M., Roper S., Fremont D.H., Wang D. Seroprevalence of Sars-Cov-2 antibodies in children and adults in St. Louis, Missouri, USA. mSphere. 2021;6(1):e01207– 01220. doi: 10.1128/mSphere.01207-20
8. Singh M.K., Mobeen A., Chandra A., Joshi S., Ramachandran S. A meta-analysis of comorbidities in COVID-19: which diseases increase the susceptibility of SARS-CoV-2 infection? Comput. Biol. Med. 2021;130:104219. doi: 10.1016/j.compbiomed.2021.104219
9. Khrisanfova E.N., Perevozchikov I.V. Anthropology: Textbook. 4 Ed. Moscow: Moscow State University Publishing House, 2005. 400 p. [In Russian].
10. Speransky V.S., Nikolenko V.N., Aristova I.S., Anisimova E.A., Zagorovskaya T.M. Lectures on medical anthropology. Tutorial. Saratov, 2006. 90 p.
11. Peckham H., de Gruijter N.M., Raine C., Radziszewska A., Ciurtin C., Wedderburn L.R., Rosser E.C., Webb K., Deakin C.T. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat. Commun. 2020;11(1):6317. doi: 1 10.1038/s41467-020-19741-6
12. Conti P., Younes A. Coronavirus COV-19/ SARS-CoV-2 affects women less than men: clinical response to viral infection. J. Biol. Regul. Homeost. Agents. 2020;34(2):339–343. doi: 10.23812/Editorial-Conti-3
13. Gao Y.D., Ding M., Dong X., Zhang J.J., Kursat Azkur A., Azkur D., Gan H., Sun Y.L., Fu W., Li W., … Akdis C.A. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76(2):428– 455. doi: 10.1111/all.14657
14. Davies N.G., Klepac P., Liu Y., Prem K., Jit M.; CMMID COVID-19 working group; Eggo R.M. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat. Med. 2020;26(8):1205– 1211. doi: 10.1038/s41591-020-0962-9
15. Ayoub H.H., Chemaitelly H., Mumtaz G.R., Seedat S., Awad S.F., Makhoul M., Abu-Raddad L.J. Characterizing key attributes of COVID-19 transmission dynamics in China’s original outbreak: Model-based estimations. Glob. Epidemiol. 2020;2:100042. doi: 10.1016/j.gloepi.2020.100042
16. Bergman J., Ballin M., Nordström A., Nordström P. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study. Eur. J. Epidemiol. 2021;36(3):287– 298. doi: 10.1007/s10654-021-00732-w
17. Guan W.J., Liang W.H., Zhao Y., Liang H.R., Chen Z.S., Li Y.M., Liu X.Q., Chen R.C., Tang C.L., Wang T., … China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur. Respir. J. 2020;55(5):2000547. doi: 10.1183/13993003.00547-2020
18. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., … Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7
19. Vertkin А.L., Askarov A.R., Zayratyants O.V., Rudnitskaya М.А. Comorbid diseases and the structure of mortality in patients with a new coronavirus infection. Lechashchiy vrach = Therapist. 2022;(7-8):10–13. [In Russian]. doi: 10.51793/OS.2022.25.8.001
20. Chadeau-Hyam M., Bodinier B., Elliott J., Whitaker M.D., Tzoulaki I., Vermeulen R., Kelly-Irving M., Delpierre C., Elliott P. Risk factors for positive and negative COVID-19 tests: a cautious and indepth analysis of UK biobank data. Int. J. Epidemiol. 2020;49(5):1454–1467. doi: 10.1093/ije/dyaa134
21. Black J.R.M., Bailey C., Przewrocka J., Dijkstra K.K., Swanton C. COVID-19: the case for healthcare worker screening to prevent hospital transmission. Lancet. 2020;395(10234):1418–1420. doi: 10.1016/S0140-6736(20)30917-X
22. Gómez-Ochoa S.A., Franco O.H., Rojas L.Z., Raguindin P.F., Roa-Díaz Z.M., Wyssmann B.M., Guevara S.L.R., Echeverría L.E., Glisic M., Muka T. СOVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am. J. Epidemiol. 2021;190(1):161–175. doi: 10.1093/aje/kwaa191
Review
Views:
708
Email this article 